ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

30 links0 made here, not in the record27 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03155620Targeted Therapy Directedby Genetic Testing inTreating Pediatric PatientsWith Relapsed or RefractoryAdvanced Solid Tumors,Non-Hodgkin Lymphomas, orHistiocytic Disorders (TheNational Cancer Institute (NCIPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 13 · ClinicalTrials.gov record · Version of 2026-11-13Version of 2026-11-13CONDITIONSHistiocytic SarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Xanthogranuloma, JuvenileThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Histiocytosis, Langerhans-C…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionGliomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.EpendymomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Sarcoma, EwingThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.HepatoblastomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.MedulloblastomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.NeuroblastomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Lymphoma, Non-HodgkinThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.OsteosarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Neuroectodermal Tumors, Pri…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Central Nervous System Neop…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Rhabdoid TumorThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.SarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.RhabdomyosarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Wilms TumorThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSEnsartinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedErdafitinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedIvosidenibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLarotrectinibEntry “Larotrectinib Sulfate”, read b…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOlaparibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPalbociclibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLY3023414Entry “Samotolisib”, read by our name…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSelpercatinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSelumetinib sulfateIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTazemetostatIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTipifarnibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedUlixertinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVemurafenibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Ensartinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Ensartinib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3EnsartinibClaude Opus 5.5TestedCurrent
Nov 3ErdafitinibClaude Opus 5.5TestedCurrent
Nov 3IvosidenibClaude Opus 5.5TestedCurrent
Nov 3LarotrectinibClaude Opus 5.5TestedCurrent
Nov 3OlaparibClaude Opus 5.5TestedCurrent
Nov 3PalbociclibClaude Opus 5.5TestedCurrent
Nov 3LY3023414Claude Opus 5.5TestedCurrent
Nov 3SelpercatinibClaude Opus 5.5TestedCurrent
Nov 3Selumetinib sulfateClaude Opus 5.5TestedCurrent
Nov 3TazemetostatClaude Opus 5.5TestedCurrent
Nov 3TipifarnibClaude Opus 5.5TestedCurrent
Nov 3UlixertinibClaude Opus 5.5TestedCurrent
Nov 3VemurafenibClaude Opus 5.5TestedCurrent
Nov 13The record itselfClinicalTrials.gov recordVersion of 2026-11-13Record change
Nov 18EnsartinibRule based · role ruleTestedAgrees
Nov 18ErdafitinibRule based · role ruleTestedAgrees
Nov 18IvosidenibRule based · role ruleTestedAgrees
Nov 18LarotrectinibRule based · role ruleTestedAgrees
Nov 18OlaparibRule based · role ruleTestedAgrees
Nov 18PalbociclibRule based · role ruleTestedAgrees
Nov 18LY3023414Rule based · role ruleTestedAgrees
Nov 18SelpercatinibRule based · role ruleTestedAgrees
Nov 18Selumetinib sulfateRule based · role ruleTestedAgrees
Nov 18TazemetostatRule based · role ruleTestedAgrees
Nov 18TipifarnibRule based · role ruleTestedAgrees
Nov 18UlixertinibRule based · role ruleTestedAgrees
Nov 18VemurafenibRule based · role ruleTestedAgrees
As of nowHistiocytosis, Langerhans-CellRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.